Biomedical catalyst 2017 round 3: feasibility studies

The aim of this competition is to support the development of innovative healthcare technologies and processes. These may include:

• disease prevention and proactive management of health and chronic conditions
• earlier and better detection and diagnosis of disease, leading to better patient outcomes
• tailored treatments that either change the underlying disease or offer potential cures

The biomedical catalyst has 4 types of funding award designed to support small to medium enterprises (SMEs) that are developing a product or process. It helps them progress from initial concept through to late-stage development.

Each type of award has a different scope. You should apply only if your project fits a specific competition scope.

This is a feasibility competition which is looking to fund projects that explore and evaluate the commercial potential of innovative scientific ideas by:

• reviewing research evidence and identifying possible applications
• assessing business opportunities
• investigating the intellectual property position
• validating initial concepts or existing pre-clinical work through experimental studies
• identifying areas for further development

Eligibility

You must:

• be a UK-based SME to lead a project
• work on your own or with other UK SMEs or research organisations
• carry out your project work in the UK
• be ready to start your project by 1 February 2018 and finish by 1 February 2019

Projects are expected to range in size up to £200,000.

Projects should last no longer than 12 months.

Your project must focus on technical feasibility studies. You could get up to 70% of your eligible project costs if you are an SME.